SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-041735
Filing Date
2024-05-10
Accepted
2024-05-10 16:15:43
Documents
16
Period of Report
2024-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0205779-8k_therape.htm   iXBRL 8-K 26814
2 THERAPEUTICSMD ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS ea0205779ex99-1_therape.htm EX-99.1 12818
3 GRAPHIC image_002.gif GRAPHIC 43
4 GRAPHIC image_002.jpg GRAPHIC 8019
  Complete submission text file 0001213900-24-041735.txt   229441

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE txmd-20240510.xsd EX-101.SCH 3033
6 XBRL LABEL FILE txmd-20240510_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE txmd-20240510_pre.xml EX-101.PRE 22371
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0205779-8k_therape_htm.xml XML 3679
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 24935065
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)